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Abstract
Human papillomaviruses (HPVs) are DNA viruses associated with major human cancers. As such there is a strong interest in
developing new means, such as vaccines and microbicides, to prevent HPV infections. Developing the latter requires a
better understanding of the infectious life cycle of HPVs. The HPV infectious life cycle is closely linked to the differentiation
state of the stratified epithelium it infects, with progeny virus only made in the terminally differentiating suprabasal
compartment. It has long been recognized that HPV must first establish its infection within the basal layer of stratified
epithelium, but why this is the case has not been understood. In part this restriction might reflect specificity of expression of
entry receptors. However, this hypothesis could not fully explain the differentiation restriction of HPV infection, since many
cell types can be infected with HPVs in monolayer cell culture. Here, we used chemical biology approaches to reveal that
cell cycle progression through mitosis is critical for HPV infection. Using infectious HPV16 particles containing the intact viral
genome, G1-synchronized human keratinocytes as hosts, and early viral gene expression as a readout for infection, we
learned that the recipient cell must enter M phase (mitosis) for HPV infection to take place. Late M phase inhibitors had no
effect on infection, whereas G1, S, G2, and early M phase cell cycle inhibitors efficiently prevented infection. We conclude
that host cells need to pass through early prophase for successful onset of transcription of the HPV encapsidated genes.
These findings provide one reason why HPVs initially establish infections in the basal compartment of stratified epithelia.
Only this compartment of the epithelium contains cells progressing through the cell cycle, and therefore it is only in these
cells that HPVs can establish their infection. By defining a major condition for cell susceptibility to HPV infection, these
results also have potentially important implications for HPV control.
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Introduction
Papillomaviruses (HPV) are small, non-enveloped, double
stranded DNA viruses that infect the cutaneous and/or mucosal
epitheliuminmanyvertebrates [1].Over 100humanpapillomavirus
(HPV) genotypes are categorized as high risk (HPV16 and HPV18)
or low risk (HPV6 and HPV11) depending on their oncogenicity.
High risk genotypes are causally associated with anogenital cancers
including nearly 100% of cervical carcinomas, the second leading
cause of death from cancer in women worldwide [1–3]. HPV is also
associated with ,25% of head and neck cancers, the sixth most
common cancer in the United States [4,5].
The HPV life cycle is tightly linked to the differentiation of its
host epithelial cells [6,7]. This complex life cycle includes a)
infection and establishment of the viral DNA as a multicopy
nuclear plasmid, which only occurs in dividing basal cells of
stratified epithelium; b) maintenance of the viral DNA at low copy
number in dividing basal epithelial cells; and c) high copy number
DNA amplification and encapsidation in non-dividing, terminally
differentiated epithelial cells to yield progeny virions. HPV early
genes are expressed throughout this life cycle, while late capsid
genes L1 and L2 are only expressed in terminally differentiated
epithelial cells. The mechanisms controlling this life cycle,
particularly the restriction of HPV infection and DNA establish-
ment to dividing basal cells, are not well understood.
The tight link between keratinocyte differentiation and the HPV
life cycle has made large scale production of mature infectious
HPV particles difficult, greatly restricting studies of the mecha-
nisms of natural HPV infection [8,9]. Recently developed
transfection methods that generate large yields of virus particles
and efficient encapsidation of target plasmids as large as the full
length ,8 kb HPV genome have overcome this limitation [10,11].
This technique provides a genetically modifiable, high yield source
of infectious HPV and HPV pseudoviruses expressing reporter
genes for studies of different early steps of HPV infection including
virion binding, endocytosis, uncoating of the virion capsid, release
from the endosome, trafficking to the nucleus, delivery of viral
DNA to the nucleus, and transcription of encapsidated genes.
To define the pathways and mechanisms involved in these early
steps of HPV infection, we tested approximately 5,000 bioactive
compounds with known mechanisms of action for effects on the
entry of HPV capsids containing reporter genes or the full HPV
genome, and identified a subset of cell cycle inhibitors that
completely blocked wild type HPV infection. Our further studies
PLoS Pathogens | www.plospathogens.org 1 February 2009 | Volume 5 | Issue 2 | e1000318showed that cell cycle progression through early stages of mitosis is
critical for successful HPV infection. These findings reveal new
insights into the mechanism by which HPV infects cells and provide
onereasonwhyHPVinfectsonlyundifferentiated,proliferatingcells.
These results also provide new leads for developing preventive and
therapeutic strategies against HPV infection.
Results
Cell cycle inhibitors block HPV infection
To identify mechanistic pathways and informative modulators
of HPV infection, we tested nearly 5,000 compounds in known
bioactive molecule libraries from Prestwick (Prestwick Chemicals)
and LOPAC (Library of Pharmacologically Active Compounds,
Sigma), using HPV pseudovirions containing an SV40 promoter-
driven secreted alkaline phosphatase (SEAP) reporter gene
(hpvSEAP). High activity effectors identified in this assay were
retested in a second infectivity assay using HPV pseudovirions
containing renilla luciferase driven by the natural HPV16
promoter (hpv16wpA-RL) to exclude false positive compounds
that may selectively affect the SV40 promoter or alkaline
phosphatase (data not shown). This screening assay was performed
in human kidney 293T cells owing to the high signal to noise
ration, and resulting high z scores obtained in this cell line.
Secondary screens performed in HaCaT cells, an immortalized
line of human keratinocytes, which are natural host cells for HPV
infection, confirmed the validity of the hits, as indicated below.
Among the confirmed hits identified in the primary screen were
cell cycle inhibitors etoposide [12] and aphidicolin [13], which
showed the most significant and consistent inhibition of HPV
infection in 293 cells both using HPV16 pseudoviruses expressing
SEAP or renilla luciferase reporter genes (data not shown), or
using intact infectious HPV16 virus in which we scored for early
gene expression (see Figure S1). The levels of inhibition achieved
with these drugs was greater than that achieved with neutralizing
antibody to HPV16 (Figure S1A), and were specific to virally
expressed gene as the drugs had no effect on cellular b-actin
expression (Figure S1B). In the more physiologically relevant
HaCaT cells, these two drugs, along with another cell cycle
inhibitor 5-fluorouracil (5-FU) [14], all were very robust in
inhibiting infectivity (Figure 1A) at concentrations that did not
have any effect on cell viability (Figure 1B). These results
demonstrate that the original screen, which was done in 293T
cells, was successful in identifying drugs that can inhibit HPV
infection in a more relevant cell type. More importantly our results
suggested that the cell cycle is critical for HPV infection.
To ensure that the negative effects of these drugs on early steps
in HPV infection were due to their inhibition of the cell cycle, and
not other activities such as the induction of DNA damage
responses, we arrested the cell cycle using a non-chemical method,
serum starvation. HaCaT cells incubated in serum free medium
showed complete cell cycle arrest at G1 phase and dramatic
inhibition of HPV infection (Figure 2A and 2B). However, when
the cell cycle was released by serum addition at the time of HPV
inoculation, HPV infection was not inhibited, but enhanced about
Author Summary
Human papillomaviruses (HPV), which comprise more than
100 genotypes, are the most prevalent sexually transmit-
ted infection and are associated with multiple human
cancers including all cervical cancers, many other anogen-
ital cancers, and 25% of head and neck cancers. The HPV
life cycle is closely linked to epithelial differentiation of skin
keratinocytes, with initial infection occurring only in the
undifferentiated proliferating basal compartment of the
epithelium and progeny virus production only in the
terminally differentiated suprabasal compartment. So far,
little is known about how host cells restrict the HPV life
cycle to specific stages of skin cell development. Here, by
identifying small molecule inhibitors of HPV infection, we
discovered that cell cycle progression through mitosis is
critical for the establishment of HPV infection. In addition,
our further chemical genetic dissection of this process
showed that early steps of mitosis are required for HPV
infection and early gene expression. Our findings provide
one reason why HPV only infects undifferentiated prolif-
erating cells and provide new leads for the development of
preventive and therapeutic strategies against HPV infec-
tion.
Figure 1. Selected cell cycle inhibitors abrogate HPV infection. The reporter RL activity (A) and cell viability (B) were measured by Renilla
Luciferase Assay System (Promega) and CellTiter-Glo Luminescent cell viability assay (Promega), respectively. Human keratinocyte HaCaT cells were
inoculated with HPV16 LCR-driven RL containing pseudovirion hpv16wpA-RL after 4 hr pre-treatment with 3 mM of each compound, and reporter
expression/cell viability scored 48 hours later. The expression value is shown as % infectivity or % viability to untreated cells with hpv16wpA-RL.
doi:10.1371/journal.ppat.1000318.g001
Host Cell Mitosis Is Critical for HPV Infection
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necessary for HPV early infection and viral gene expression.
Cell cycle progression through mitosis is critical for HPV
infection
To define which cell cycle step(s) is critical for early HPV
infection, we synchronized HaCaT cells with aphidicolin or
etoposide and then tightly controlled subsequent cell cycle
progression. In the first set of experiments (indicated as ‘‘No
inhibition’’; Figure 3A and 3B), HaCaT cells were synchronized in
G1 phase by a 24 hr aphidicolin treatment, inoculated with
hpv16wpA-RL virions, and then 4 hr later, released by removing
aphidicolin from the culture medium. After 48 hr incubation, the
infected HaCaT cells expressed high levels of RL. The reporter
gene expression levels under these ‘‘no inhibition’’ positive control
conditions were set to 100% infection and used to normalize the
early gene expression levels from the other experimental
conditions (Figure 3B). In the second (G1 arrest; Figure 3A and
3B) and third (G2 arrest; Figure 3A and 3B) conditions used, cells
were treated with either aphidicolin or etoposide for 24 hr, after
which hpv16wpA-RL virions were added. The cell cycle was
blocked at G1/S and G2 by aphidicolin and etoposide,
respectively, and HPV infection was significantly and consistently
inhibited under both conditions (Figure 3A and 3B). These
conditions were the same as used in Figure 1, and the flow
cytometric analyses shown in Figure 3 confirmed effective cell
cycle block by these aphidicolin and etoposide at the concentra-
tions used in Figure 1. In the fourth condition (S phase progress;
Figure 3A and 3B), we synchronized the cells in G1/S phase by
24 hr aphidicolin treatment, then added hpv16wpA-RL virions
and, 4 hr later, replaced aphidicolin with etoposide. When
aphidicolin was replaced by etoposide, cell cycle progressed from
G1 arrest through S phase to G2 arrest, allowing us to test whether
S phase progression supports HPV early infection. However, this
experiment showed no difference in reporter gene expression from
G1/S or G2 arrest by aphidicolin and etoposide (Figure 3A and
3B). In the fifth condition (S & M phase progress; Figure 3A and
3B), after 24 hr synchronization and subsequent hpv16wpA-RL
virion addition, the cell cycle was released for 20 hrs, followed by
cell cycle arrest in G2 phase with etoposide, allowing the cells to
progress through one complete round of the cell cycle, including
M phase. Interestingly, one round of M phase progression was
sufficient for HPV infection and gene expression (Figure 3A and
3B). Our further testing with wild type HPV16 virions confirmed
that one round of the cell cycle through M phase is sufficient for
HPV early gene expression (Figure S2). These results imply that
cell cycle progression through mitosis is critical for early steps of
HPV infection. Consistent with this premise, HPV gene expression
levels were further enhanced when the cell cycle was released for
progressively longer periods before G2 arrest, eventually reaching
levels well above the control ‘‘no arrest’’ conditions (Figure 4). This
suggests that G2 arrest following a complete cell cycle might
provide a better host cell environment for viral gene expression
once the virus enters nucleus.
Early prophase, but not late prophase or metaphase, is
critical for HPV early infection
To define further the stages of mitosis and associated cellular
functions that are or are not required to support HPV early
infection, we tested monastrol [15], which inhibits mitotic spindle
formation during late prophase and metaphase in early to mid
mitosis. Interestingly, monastrol, which induced cell cycle arrest in
M as expected (Figure 5B) showed no inhibitory effect on HPV
infection in HaCaT cells (Figure 5A). Indeed at high concentra-
tions of monastrol, there was a slight but reproducible increase in
HPV infectivity. Thus HPV infection can efficiently arise in cells
inhibited in late prophase/metaphase. These results, taken
together with those in Figure 3 narrowed down the critical stage
of the cell cycle for HPV infection to likely be early prophase.
Cellular events in early prophase include nuclear envelope (NE)
breakdown and changes in chromatin structure. Phosphorylation
of NE components by CDK1 is critical for these events in early
prophase [16–18]. To examine whether entry into early prophase
is critical for HPV infection, we tested hpvSEAP infection in 293T
cells treated with the CDK1 inhibitor, purvalanol A [19].
Purvalanol A inhibited HPV infection dose-specifically, with
12 mM both significantly arresting the cell cycle at G2/M phase
and inhibiting HPV infection ,5-fold (Figure 6A and 6B). These
Figure 2. Cell cycle arrest by serum starvation abrogates HPV infection. (A) After 24 hr incubation in serum-free DMEM, HaCaT cells were
inoculated with HPV pseudovirion hpv16wpA-RL, and RL activity was measured after 2 d. For serum conversion, serum-free DMEM was replaced with
10% FBS/DMEM before virus inoculation. The expression value is shown as % infectivity to untreated cells with hpv16wpA-RL inoculation. Columns,
mean; bars, SD. (B) Flow cytometry was performed to confirm cell cycle arrest by serum starvation. The solid line indicates the HaCaT cells incubated
with serum-free DMEM for 24 h, and the gray shaded area indicates control HaCaT cells in DMEM with 10% FBS.
doi:10.1371/journal.ppat.1000318.g002
Host Cell Mitosis Is Critical for HPV Infection
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critical for HPV infection.
Influenza virus genome delivery via nuclear pores is
unaffected by cell cycle inhibitors that block HPV
infection
HPV minor capsid protein L2 has nuclear localization signals
and, consequently, it has been hypothesized that L2 direct nuclear
pore-mediated import of HPV DNA during infection [20]. One
virus that is well established to import its genome into intact nuclei
via nuclear pores is influenza virus [21,22]. To test whether HPV
and influenza virus share similar nuclear entry mechanisms, we
treated 293T cells in parallel with either a recombinant influenza
virus expressing renilla luciferase or renilla luciferase-expressing
HPV pseudovirions, in the presence and absence of etoposide and
aphidicolin. While etoposide and aphidicolin efficiently blocked
HPV infection, as before, they did not significantly affect influenza
virus infection (Figure 7A), showing that their effects on HPV
could not be explained by effects on import via nuclear pores. We
also observed in HaCaT cells the same difference in cell cycle
dependency when those cells were arrested by serum starvation
and inoculated with the same renilla luciferase-expressing HPV
pseudovirions or recombinant influenza virus. Under these
conditions (Figure 7B), HPV infection was inhibited over 50 fold
Figure 3. Cell cycle progression through M phase is critical for HPV infection. (A) HaCaT cells were synchronized with aphidicolin (sets 1, 2,
4, and 5) and etoposide (set 3) 24 hrs before hpv16wpA-RL inoculation. Cell cycle progression was released in set 1 and kept blocked in set 2 and 3
using aphidicolin and etoposide, respectively. In set 4, cell cycle progressed through S phase but arrested at G2 phase by switching the compounds
in medium from aphidicolin to etoposide. In set 5, cell cycle was released for 20 hrs to progress through M phase and arrest at G2 phase by etoposide
addition. Experimental protocols are shown as diagrams. Solid arrow and dotted arrow indicate aphidicolin and etoposide in cell culture medium,
respectively. Histograms show the results of flow cytometry analysis following propidium iodide staining at 0, 24, and 48 hr time points using a cell
cycle analysis program of FlowJo. (B) The reporter RL activity was measured by Renilla Luciferase Assay System (Promega).
doi:10.1371/journal.ppat.1000318.g003
Figure 4. Cell cycle progression through M phase is critical for
HPV infection. Cell cycle release after 24 hr G1 arrest was extended to
24 and 30 hrs before G2 arrest by etoposide. Expression of HPV16 early
RNA transcripts was measured using E7 specific primers. Columns,
mean; bars, SD. We could not detect any signal above the background
in reverse transcriptase–negative controls, indicating that only mRNA
expressed from infected virus could be detected (data not shown).
doi:10.1371/journal.ppat.1000318.g004
Host Cell Mitosis Is Critical for HPV Infection
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fold, likely due to the general suppression of cell metabolism upon
serum starvation.
Discussion
HPVs are pathogens of tremendous clinical importance due to
their strong associations with multiple common human malignan-
cies and because they are the most common sexually transmitted
pathogens. Some oncogenic mechanisms of HPV are well known,
especially those of viral oncoproteins E6 and E7 [23]. However,
many other basic mechanisms of the HPV life cycle are largely
unknown including how HPV selectively infects only undifferen-
tiated basal cells. In this report, we define one of the bases for this
restriction by showing that cell cycle progression into mitosis and,
in particular, events in early prophase are critical for establishing
HPV infection.
Virusesemployvariedstrategiestodelivertheirgeneticmaterialto
the nucleus for replication and viral gene expression [24]. While
adenoviruses dissociate their capsids in the cytoplasm and import
naked genomic DNA into the nucleus, herpesvirus virions release
their genome into the nucleus without any extensive capsid
disassembly, and polyomaviruses and parvoviruses transport the
entire capsid into the nucleus. The nuclear import strategies of
papillomaviruses have been largely unexplored, mainly because the
meansforproducinghigh yieldsofinfectiousvirus have onlyrecently
been attained[10,11].In the presentstudy,using infectiouswild type
HPV16 virions, we found that events in the early prophase segment
of mitosis are critical for establishing HPV infection, as assayed by
introduction and expression of HPV-encapsidated DNA in the
nucleus. As discussed below, these events could include nuclear
envelope breakdown, cytoskeleton restructuring, and subnuclear
structure changes as well as the specific expression of one or more
genes or gene combinations in early mitosis.
One critical event in early mitosis is nuclear envelope (NE)
breakdown, which is triggered by a signal cascade that involves
polo I like kinase 1 (plk1) and cyclin B1-associated CDK1
[16,17,25]. Using a chemical inhibitor of CDK1, purvalanol A
Figure 5. Late M phase arrest does not affect HPV infection. (A) HaCaT cells were treated with different concentrations of monastrol, and
hpv16wpA-RL infectivity was assessed as above. Dotted line is for mock-infected cells. (B) Cell cycle arrest at M phase by monastrol (100 mM) was
confirmed using flow cytometry. Red and blue histograms indicate the cell cycle status of DMSO and monastrol-treated cells, respectively.
doi:10.1371/journal.ppat.1000318.g005
Figure 6. Early M phase arrest by CDK1 inhibition interferes with HPV infection. (A) 293T cells were treated with a CDK1 inhibitor,
purvalanol A (3, 6, and 12 mM), and inoculated with hpvSEAP. SEAP activity was assayed after 48 hrs incubation as described in Materials and
Methods. p,0.05, significantly different from DMSO control. Columns, mean; bars, SD. (B) Cell cycle arrest at M phase by purvalanol A (12 mM) is
shown. Red and blue histograms indicate the cell cycle status of DMSO and purvalanol A-treated cells, respectively.
doi:10.1371/journal.ppat.1000318.g006
Host Cell Mitosis Is Critical for HPV Infection
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infection by HPVs (Figure 6A). Therefore, our data are consistent
with the possibility that NE breakdown is necessary for the HPV
encapsidated DNAs to enter the nucleus. This is similar to the
strategy thought to be employed by simple retroviruses to allow
nuclear entry and integration of their proviral genomes [26,27].
The process that initiates nuclear envelope breakdown is not fully
understood. While the phosphorylation of NE components by
CDK1 correlates with NE breakdown, and inhibition of cdk1
prevents NE breakdown [16,17], some have argued that NE
breakdown is initiated by mechanical tension induced by spindle
microtubules, leading to holes in the NE [28,29]. Consistent with
this hypothesis, the microtubule minus end motor, dynein,
translocates to the outer face of the NE just before NE breakdown.
This model for NE breakdown by mechanical tension has an
interesting connection to HPV infection. L2 binds to dynein and
this is thought to allow L2:HPV DNA complexes to be
translocated along microtubules towards the nucleus [30]. Thus,
dynein-mediated trafficking of HPV-encapsidated DNA cargo
may not just contribute to movement of the encapsidated DNA to
the intracytoplasmic destination of dynein, the microtubule
organizing center, but might also contribute to nuclear localization
if the above described model for NE breakdown is correct.
Another notable cellular event in early mitosis is the
reorganization of cytoplasmic microtubules to support mitotic
spindle formation, chromosome segregation, and cell division
[31,32]. Like many other viruses, HPV utilizes microtubules to
traffic from the cell surface to the nucleus [30], although many
details of this process remain to be understood. Our results are
consistent with the possibility that effective HPV entry and/or
Figure 7. Cell cycle arrest does not inhibit influenza virus. (A) After 24 hr synchronization with aphidicolin and 4 hr treatment with etoposide
or aphidicolin (3 mM each), 293T cells were inoculated in parallel with hpv16wpA-RL or an influenza virus vector in which the hemagglutinin and
neuraminidase open reading frames in viral RNA were replaced with those of vesicular stomatitis virus glycoprotein and RL, respectively [50]. (B) After
24 hr synchronization in serum-free DMEM, HaCaT cells were inoculated with hpv16wpA-RL and the RL-expressing influenza virus as (A) in the
presence or absence of FBS. RL activity was measured after 48 hrs, as described in Materials and Methods, normalized to RL activity in equivalently
inoculated cells maintained in 10% FBS, and expressed in the histograms as % infectivity. Columns, mean; bars, SD.
doi:10.1371/journal.ppat.1000318.g007
Host Cell Mitosis Is Critical for HPV Infection
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microtubules, such as the interaction of microtubules with host
chromosomes in early mitosis.
In addition, restructuring of PML oncogenic bodies (PODs) and
chromatin in early mitosis could be necessary for establishing HPV
infection in the nucleus. PODs, also known as ND10, are
subnuclear bodies implicated in multiple cellular functions
including transcription, DNA repair, viral defense, stress, cell
cycle regulation, proteolysis and apoptosis [33,34]. PODs are also
the final destination of HPV DNA during the initial steps in
infection and sites at or near which HPV DNA replication and
transcription occur [35,36]. PODs are dynamically restructured
during S and M phases, responding to changes in chromatin
organization [37]. Thus, structural changes of PODs in early
mitosis might be critical for HPV DNA localization to its POD
destinations during the establishment of HPV infection. Other
host mechanisms associated with chromatin structure in early
mitosis might also contribute to structural changes of the incoming
HPV DNA and thereby facilitate viral gene expression and
replication inside the nucleus. Little is currently known about HPV
chromatin structure and its contribution to viral gene expression.
Many genes such as polo-like kinases and aurora kinases are
exclusively expressed in early mitosis to certify completion of DNA
replication, overcome mitotic checkpoint, and initiate mitosis [38].
Beyond the potential mechanisms of cell cycle dependence
suggested above, host genes or gene combinations specifically
expressed only in early mitosis might have essential roles for HPV
entry steps and/or HPV early gene expression.
HPV is thought to be able to infect the proliferating basal layer
of stratified epithelium only when wounds allow HPV to penetrate
the physical barrier of upper skin layers. Wounding also can
provide HPV particles access to laminin 5 or heparin sulfate
moieties, both components of the extra cellular matrix (ECM)
component of the epithelial basement membrane for which HPV
particles have high affinity, thereby localizing the virus particles to
basal surface of epithelial cells it needs to infect [39,40]. Laminin 5
is also the ECM partner of integrin a6/b4, which has been
reported by some investigators to be an entry receptor for HPVs
[39–41]. Our results suggest that wound healing might increase
the efficiency with which the HPV DNA becomes established as a
nuclear plasmid in basal cells, because the basal cells are then in a
hyperproliferative state [42]. HPV may also provide a mitogenic
signal upon binding to cell surface receptors [43,44], though if so,
that signal is insufficient to overcome serum starvation-induced
cell cycle arrest in HaCaT cells (Figure 2A and 2B). Regardless of
why the cell is cycling, our data indicate that its movement
through mitosis is one critical step in establishing HPV infection.
To further confirm physiologically relevance regarding the cell
cycle dependence of HPV infection, it would be necessary to
examine these results in primary keratinocytes and in vivo models
such as mouse and non-human primate. In addition, real-time
particle imaging studies could be employed to identify what
specific steps in infection are blocked upon cell cycle arrest;
however, the ability to interpret accurately such imaging studies
rests on the ability to distinguish particles leading to infectious
events from the vast majority of particles that give rise to abortive
or non-infections events. To date no imaging method exists able to
make such a distinction at the individual particle level.
The recent development of HPV vaccines offers an extremely
important avenue for control of HPV infections and their associated
cancers [45]. Nevertheless, due to limitations of recently approved
HPV vaccines, including incomplete coverage of high-risk HPV
genotypes and high cost, there is an urgent need to identify other
approaches to prevent HPV infections. One potentially valuable
approach to prevent STDs, including genital HPV infections, could
be ready access to effective microbicides [46]. From this perspective,
our findings provide a new target mechanism for preventing initial
HPV infection and blocking further spread. Recently, Schiller’s
group has developed an in vivo mouse model of HPV infection in
mouse reproductive organs [47]. Using this method, our small
molecule HPV inhibitors are now undergoing tests to assess their
efficacy and therapeutic potential. In this context, our high
throughput chemical biology screening approach that led to the
current study on the role of cell cycle in HPV infection also has
successfully identified many other compounds that inhibit HPV
infection, and their initial evaluation points to promising lead
compounds for further development as microbicides. It remains to
be seen whether establishment of a robust high throughout screen
using human keratinocytes instead of a surrogate cell type, here
293T cells, could identify additional small molecules and possibly
other cellular processes critical for HPV infection in its natural host.
Materials and Methods
Plasmids
pEF399, containing the complete W12E HPV16 genome [48], and
all other plasmids used for virus packaging were previously described
[11]. pSEAP (pSEAP-control) for expression of secreted alkaline
phosphatase (SEAP) was purchased from Clontech. pHPV16wpA-RL
wascloned withHPV16long control region (LCR,nucleotideposition
7155 - 861), into pRL-null (Promega) to prepare a Renilla luciferase
reporter system driven by native HPV16 promoter.
Cell lines
Human embryonic kidney cell line 293T from ATCC, and its
enhanced SV40 T antigen-expressing daughter cell line 293TT
[10] from John Schiller, were maintained in Dulbecco’s modified
eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (FBS) (Invitrogen). Immortalized human keratinocyte cell
line HaCaT [49] was maintained in F-media (Invitrogen, 3 parts
F-12 and 1 part DMEM), supplemented with 10% FBS.
Production of virus particles
HPV virions and pseudovirions were prepared as described
previously [11]. Briefly, we cotransfected 293TT (provided by
John Schiller) cells with HPV16 capsid protein expression plasmid
as well as one of the target DNAs for encapsidation. After 48 h at
37uC, cells were harvested and virions were purified using
Optiprep gradient centrifugation. Influenza virus containing RL
[50] was provided by Yoshihiro Kawaoka.
Small molecule compounds and libraries
Known Bioactive Library (KBA01) consists of 3 commercially
available collections totaling 4,160 compounds. KBA01 consists of
880 high purity compounds of known safety and bioavailability in
humans of which over 85% are marketed drugs from Prestwick
Chemical. The Prestwick compounds cover several therapeutic
areas including neuropsychiatry, cardiology, immunology, inflam-
mation, analgesia, etc. Also included in the KBA01 library is 2000
diverse FDA approved drugs and natural products from Spectrum
Chemical Collection From Microscource Discovery Systems, Inc.
and 1280 compounds from the LOPAC of Sigma representing
marketed drugs, failed development candidates and ‘‘gold
standards’’ that have well-characterized activities. These com-
pounds are the results of lead optimization efforts and have been
rationally designed by structure-activity relationship studies. The
NCI03 library consists of 235 natural products that were selected
from the NCI open repository on the basis of structural diversity
Host Cell Mitosis Is Critical for HPV Infection
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5-Fluorouracil, CGP-74514A were purchased from Sigma.
High throughput screening
293TT cells in 384-well plates were treated with 3.3 mMo f
library compounds for 4 hrs and inoculated with hpvSEAP at 50
vge (viral genome equivalent)/cell for 48 hrs. Culture supernatant
2.5 ml was used for virus infectivity assay using a Phospha-Light a
chemiluminescent alkaline phosphatase assay (Applied Biosystems)
and cell lysate was used for cell viability assay using CellTiter-Glo
Luminescent cell viability assay (Promega). Biomek FX (Beckman
Coulter) was used for automated liquid handling and a Victor 3-V
plate reader (Perkin Elmer) was used for measuring luminescence.
Screening was performed in the Small Molecule Screening Facility
at the University of Wisconsin Comprehensive Cancer Center.
Infectivity assay
The activity of pSEAP-control-encapsidated pseudovirions
(hpvSEAP) was measured using a Phospha-Light a chemiluminescent
alkaline phosphatase assay (Applied Biosystems) and the activity of
pHPV16wpA-RL-encapsidating pseudovirions (hpv16wpA-RL) was
assayed using Renilla Luciferase Assay System (Promega). Infectivity
of wild type HPV16 virions was examined by quantitative reverse
transcriptase PCR (qRT-PCR) by amplifying viral mRNA signals
from HPV16-treated 293TT cells. 293TT cells were inoculated with
50–100 vge/cell of packaged virus and incubated for 48 h at 37uC.
Total RNA was isolated using the RNeasy total RNA purification kit
(Qiagen), treated with RQ DNaseI (Promega) to remove possible
DNA contaminants, purified again on RNeasy columns to remove
DNaseI, and quantified by spectrophotometer. cDNA was synthe-
sized from 20 mg of total RNA with oligo (dT) using a SuperScript
cDNA synthesis kit (Invitrogen), and qPCR was performed with
QuantiTect SYBR Green PCR Kit (Qiagen). Oligonucleotide
primers (Figure 3) were designed using the Primer3 primer design
program [51], synthesized by MWG and used at 0.5 mM for PCR
amplification for 40 cycles of 30 s denaturation at 94uC, 30 s
annealing at 55uC, and 30 s polymerization at 72uC. Obtained
values were normalized with the levels of b-actin.
Flow cytometry
The cell cycle status of treated and untreated cells was analyzed
using a propidium iodide (PI) incorporation method. Briefly,
HaCaT cells were harvest, homogenized, fixed with cold 70%
ethanol for 30 min at 220uC, and incubated with PI staining
solution (1 mg/ml RNase A, 33 mg/ml PI, 0.2% NP-40 in PBS)
for 30 min at room temperature. Stained cells were filtered
through 35 mm-pore nylon mesh cell filtering caps (Falcon) and
analyzed by flow cytometry using Becton Dickinson FACSCalibur
(488 nm laser excitation).
Supporting Information
Figure S1 Selected cell cycle inhibitors abrogate HPV infection.
HPV16 early gene (A) and b-actin expression (B) was measured by
quantitative RT-PCR. 293T cells were inoculated with wild type
HPV16 after 4 hr pre-treatment with 3 mM of each compound or
with 1:100 dilution of neutralizing antibody (H16.7E). Total RNA
was extracted after 48 hrs, and expression levels of HPV16 RNA
transcripts were measured by qRT-PCR using E7, E2, and E5
sequence specific primers (Figure S3). The expression value is
shown as % infectivity or % expression to untreated cells infected
with HPV16. We could not detect any signal above the
background in reverse transcriptase-negative controls, indicating
that only mRNA expressed from infected virus could be detected
(data not shown). Due to different characteristics of each primer
set, we observed slight differences in the quantity of mRNAs
detected in the same sample with different primer pairs. Those
differences, while not statistically significant, could reflect differ-
ences in the efficiency of each primer pair amplifying different
subsets of viral early mRNAs. Veratrine, an alkaloid drug, was one
of many small molecule compounds in the initially screened
libraries that did not affect HPV infection and was chosen as an
irrelevant negative control compound for the secondary screens.
The neutralizing antibody (H16.7E, provided by Neil Christensen
at the Pennsylvania State University, Hershey, Pennsylvania) was
used as a positive control for HPV infection inhibition.
Found at: doi:10.1371/journal.ppat.1000318.s001 (0.12 MB PDF)
Figure S2 Cell cycle progression through M phase is critical for
HPV infection. 293T cells were synchronized with aphidicolin
(sets 1, 2, 4, and 5) and etoposide (set 3) 4 hrs before wild type
HPV16 inoculation. Cell cycle progression was released in set 1
and kept blocked in sets 2 and 3 using aphidicolin and etoposide,
respectively. In set 4, cell cycle progressed through S phase but
arrested at G2 phase by switching the compounds in medium from
aphidicolin to etoposide. In set 5, cell cycle was released for 20 hrs
to progress through M phase and arrest at G2 phase by etoposide
addition. Wild type HPV16 gene expression was measured from
total RNA extracts as indicated in Figure S1 and in Materials and
Methods.
Found at: doi:10.1371/journal.ppat.1000318.s002 (0.06 MB PDF)
Figure S3 Quantitative PCR primers of HPV16 early genes. (A)
Oligonucleotide primers were designed using the Primer3 primer
design program. (B) The HPV genomic position of each primer is
indicated by an arrow.
Found at: doi:10.1371/journal.ppat.1000318.s003 (0.01 MB PDF)
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